<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299687</url>
  </required_header>
  <id_info>
    <org_study_id>OMP_CYP2C19</org_study_id>
    <nct_id>NCT02299687</nct_id>
  </id_info>
  <brief_title>Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole</brief_title>
  <official_title>A Clinical Trial to Investigate the Influence of CYP2C19 Polymorphism on Pharmacokinetic/Pharmacodynamic Characteristics of Omeprazole in Healthy Korean Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      A clinical trial to investigate the influence of CYP2C19 polymorphism on
      pharmacokinetic/pharmacodynamic characteristics of omeprazole in healthy Korean volunteers
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mean and median Intragastric PH</measure>
    <time_frame>24 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUC</measure>
    <time_frame>12 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax</measure>
    <time_frame>12 hour</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Stomach Ulcer</condition>
  <arm_group>
    <arm_group_label>CYP2C19 EM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CYP2C19 EM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CYP2C19 IM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CYP2C19 IM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CYP2C19 PM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CYP2C19 PM</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omeprazole</intervention_name>
    <arm_group_label>CYP2C19 EM</arm_group_label>
    <arm_group_label>CYP2C19 IM</arm_group_label>
    <arm_group_label>CYP2C19 PM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Are able to provide written informed consent.

          2. The subject is a healthy Korean aged 20 to 45 years, inclusive.

          3. The subject weighs at least 55 (for female, 55) to 90 kg and has a body mass index
             (BMI) range of 18 to 25 kg/m2

        Exclusion Criteria:

          1. Subjects with evidence or a history of clinically significant pulmonary,
             cardiovascular, hepatic, endocrine, hematological, neurologic or psychiatric diseases.

          2. Subjects with evidence of gastrointestinal disease which can affect the absorption of
             drug.

          3. Subjects with a history of drug abuse or a positive result in the urine drug screening
             for drug abuse

          4. Subjects who have taken any prescribed medicine or herbal medicine within 2 weeks
             before the first administration of the investigational product, any non-prescribed
             medicine or vitamin supplement within 1 week prior the first administration of the
             investigational product (if all other conditions are satisfied, subjects may be
             eligible for the trial as judged by the investigator.)

          5. Subjects who have donated a unit of whole blood within 30 days or who have
             participated in any other clinical trial within 60 days prior the first administration
             of the investigational product

          6. Subject who have history of allergy on omeprazole

          7. Subject who can not continue proper contraception method during study period.

          8. Subject with a positive urine HCG test result on screening. (in case of woman subject)

          9. Subjects who consume more than 21 units of alcohol per week (1 unit = 10 g of pure
             alcohol) or who are unable to abstain from drinking during the PK/PD testing period

         10. Subjects who consume more than 10 cigarette per day or who are unable to abstain from
             smoking during the PK/PD testing period

         11. Subjects who are unable to abstain from grapefruit or caffeine containing food 3 day
             prior the first administration of the investigational product

         12. Subjects judged not eligible for the study after reviewing the clinical laboratory
             results or other reasons by the investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2014</study_first_submitted>
  <study_first_submitted_qc>November 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>December 31, 2014</last_update_submitted>
  <last_update_submitted_qc>December 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>In-Jin Jang, MD, PhD</investigator_full_name>
    <investigator_title>Professor of clinical pharmacology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Omeprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

